Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

Last updated: March 27, 2025
Sponsor: Merck Sharp & Dohme LLC
Overall Status: Active - Not Recruiting

Phase

3

Condition

N/A

Treatment

cisplatin

durvalumab

paclitaxel

Clinical Study ID

NCT05298423
7684A-006
jRCT2021220015
MK-7684A-006
2021-005135-23
U1111-1285-3656
KEYVIBE-006
2022-502752-31
PHRR230831-006071
  • Ages > 18
  • All Genders

Study Summary

Researchers are looking for new ways to treat people with locally advanced non-small cell lung cancer (NSCLC). The goal of this study is to learn if people who receive the combination of vibostolimab and pembrolizumab (MK-7684A) live longer without the cancer getting worse and live longer overall than people who receive durvalumab.

Eligibility Criteria

Inclusion

The main inclusion and exclusion criteria include but are not limited to the following:

Inclusion Criteria

  • Has pathologically (histologically or cytologically) confirmed diagnosis of NSCLC.

  • Has Stage IIIA, IIIB, or IIIC NSCLC by American Joint Committee on Cancer Version 8

  • Is determined to have unresectable, Stage III NSCLC as documented by a multidisciplinary tumor board or by the treating physician in consultation with a thoracic surgeon

  • Has no evidence of metastatic disease, indicating Stage IV NSCLC, in whole-body fluorodeoxyglucose (FDG)-positron emission tomography (PET) or FDG-PET/ computed tomography (CT) and CT or magnetic resonance imaging (MRI) scans of diagnostic quality of chest, abdomen, pelvis and brain

  • Has measurable disease as defined by RECIST 1.1, with at least 1 lesion being appropriate for selection as a target lesion, as determined by local site investigator/radiology review

  • Has not received prior treatment (chemotherapy, targeted therapy, or radiotherapy) for their Stage III NSCLC

  • Has provided tumor tissue sample (tissue biopsy [core, incisional, or excisional])

  • Has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 assessed within 7 days prior to the first administration of study intervention

  • Has a life expectancy of at least 6 months

Exclusion Criteria

  • Has small cell lung cancer (SCLC) or tumors with the presence of small cell elements. Mixed squamous/nonsquamous tumors are eligible

  • Has received prior radiotherapy to the thorax, including radiotherapy to the esophagus, mediastinum, or for breast cancer

  • Has received major surgery (with the exception of replacement of vascular access) within 4 weeks before randomization. If the participant had a major operation, the participant must have recovered adequately from the procedure and/or any complications from the operation before starting study intervention

  • Is expected to require any other form of antineoplastic therapy, while on study

  • Has received colony-stimulating factors (e.g., Granulocyte Colony-Stimulating Factor [G-CSF], Granulocyte Macrophage Colony-Stimulating Factor [GM-CSF], or recombinant erythropoietin) within 28 days prior to the first dose of study intervention

  • Has received a live or live-attenuated vaccine within 30 days before the first dose of study intervention

  • Is currently participating in or has participated in a study of an investigational agent or has used an investigational device within 4 weeks before the first dose of study intervention

  • Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to the first dose of study medication

  • Has a known additional malignancy that is progressing or has required active treatment within the past 5 years

  • Has an active autoimmune disease that has required systemic treatment in past 2 years

  • Has a history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease

  • Has an active infection requiring systemic therapy

  • Has a known history of human immunodeficiency virus (HIV) infection

  • Has a known history of Hepatitis B (defined as hepatitis B surface antigen [HBsAg] reactive) or known active Hepatitis C virus (defined as HCV ribonucleic acid [RNA] qualitative is detected) infection

  • Has had an allogenic tissue/solid organ transplant

Pemetrexed-specific Criteria:

  • Is unable to interrupt aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), other than an aspirin dose ≤1.3 grams per day, for at least 2 days (5 days for long-acting agents [for example, piroxicam]) before, during, and for at least 2 days after administration of pemetrexed

  • Is unable/unwilling to take folic acid, vitamin B12, and dexamethasone

Study Design

Total Participants: 611
Treatment Group(s): 8
Primary Treatment: cisplatin
Phase: 3
Study Start date:
May 03, 2022
Estimated Completion Date:
August 19, 2026

Study Description

As of protocol amendment 4, participants receiving combination vibostolimab and pembrolizumab (MK-7684A) discontinued treatment due to lack of efficacy observed in other MK-7684A studies, and are given the option to transition to durvalumab therapy.

Connect with a study center

  • Instituto Médico Río Cuarto ( Site 3600)

    Rio Cuarto, Cordoba X5800
    Argentina

    Site Not Available

  • Sanatorio Parque ( Site 3602)

    Rosario, Santa Fe S2000DSV
    Argentina

    Site Not Available

  • Clinica Adventista Belgrano ( Site 3601)

    Caba, C1430EGF
    Argentina

    Site Not Available

  • Canberra Hospital ( Site 0010)

    Canberra, Australian Capital Territory 2605
    Australia

    Site Not Available

  • Icon Cancer Centre Hobart ( Site 0003)

    Hobart, Tasmania 7000
    Australia

    Site Not Available

  • Ballarat Health Services-Medical Oncology ( Site 0002)

    Ballarat Central, Victoria 3350
    Australia

    Site Not Available

  • Frankston Hospital-Oncology and Haematology ( Site 0009)

    Frankston, Victoria 3199
    Australia

    Site Not Available

  • St Vincent's Hospital-Oncology Clinical Trials ( Site 0005)

    Melbourne, Victoria 3065
    Australia

    Site Not Available

  • Hospital Nossa Senhora da Conceição ( Site 0111)

    Porto Alegre, Rio Grande Do Sul 91350-200
    Brazil

    Site Not Available

  • Instituto de Educação, Pesquisa e Gestão em Saúde ( Site 0105)

    Rio de Janeiro, 22793-080
    Brazil

    Site Not Available

  • A. C. Camargo Cancer Center-CAPEC ( Site 0102)

    Sao Paulo, 01509-010
    Brazil

    Site Not Available

  • James Lind Centro de Investigacion del Cancer ( Site 0202)

    Temuco, Araucania 4800827
    Chile

    Site Not Available

  • James Lind Centro de Investigación del Cáncer ( Site 0202)

    Temuco, Araucania 4800827
    Chile

    Active - Recruiting

  • Biocenter ( Site 0208)

    Concepcion, Biobio 4070196
    Chile

    Site Not Available

  • Biocenter ( Site 0208)

    Concepción, Biobio 4070196
    Chile

    Site Not Available

  • Bradfordhill ( Site 0200)

    Santiago, Region M. De Santiago 8420383
    Chile

    Site Not Available

  • Centro de Oncología de Precisión ( Site 0209)

    Santiago, Region M. De Santiago 7560908
    Chile

    Site Not Available

  • FALP-UIDO ( Site 0205)

    Santiago, Region M. De Santiago 7500921
    Chile

    Site Not Available

  • ONCOCENTRO APYS-ACEREY ( Site 0203)

    Viña del Mar, Valparaiso 2520598
    Chile

    Site Not Available

  • Beijing Cancer hospital-Oncology Radiotherapy Department ( Site 0309)

    Beijing, Beijing 100142
    China

    Site Not Available

  • Beijing Cancer hospital-intrathoratic deparmtment II ( Site 0328)

    Beijing, Beijing 100142
    China

    Site Not Available

  • Beijing Peking Union Medical College Hospital-pneumology department ( Site 0300)

    Beijing, Beijing 100730
    China

    Site Not Available

  • Army Medical Center of People's Liberation Army-Oncology Department ( Site 0321)

    Chongqing, Chongqing 400042
    China

    Site Not Available

  • Fujian Provincial Cancer Hospital ( Site 0316)

    Fuzhou, Fujian 350014
    China

    Site Not Available

  • Fujian Medical University Union Hospital-1 Bingfanglou ( Site 0330)

    Fuzhou Fujian, Fujian 350001
    China

    Site Not Available

  • The First Affiliated hospital of Xiamen University-oncology ( Site 0317)

    Xiamen, Fujian 361003
    China

    Site Not Available

  • Southern Medical University Nanfang Hospital-Department of Oncology ( Site 0336)

    Guangzhou, Guangdong 510515
    China

    Site Not Available

  • Fourth Hospital of Hebei Medical University ( Site 0331)

    Shijiazhuang, Hebei 050035
    China

    Site Not Available

  • Henan Cancer Hospital ( Site 0333)

    Zhengzhou, Henan 450008
    China

    Site Not Available

  • Hubei Cancer Hospital ( Site 0311)

    Wuhan, Hubei 430079
    China

    Site Not Available

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0315)

    Wuhan, Hubei 430022
    China

    Site Not Available

  • Wuhan Union Hospital Cancer Center-Cancer Center ( Site 0315)

    Wuhan, Hubei 430022
    China

    Active - Recruiting

  • Hunan Cancer Hospital ( Site 0307)

    Changsha, Hunan 410013
    China

    Site Not Available

  • Xiangya Hospital Central South University-Oncology department ( Site 0310)

    Changsha, Hunan 410008
    China

    Site Not Available

  • The Second Affiliated Hospital of Soochow University ( Site 0314)

    Suzhou, Jiangsu 215004
    China

    Site Not Available

  • Affiliated Hospital of Jiangsu University ( Site 0305)

    Zhenjiang, Jiangsu 212001
    China

    Site Not Available

  • Jilin Cancer Hospital-oncology department ( Site 0319)

    Changchun, Jilin 130012
    China

    Site Not Available

  • Shandong Provincial Hospital ( Site 0326)

    Jinan, Shandong 250001
    China

    Site Not Available

  • Qingdao Central Hospital-Endocrinology ( Site 0332)

    Qingdao, Shandong 266042
    China

    Site Not Available

  • Fudan University Shanghai Cancer Center ( Site 0304)

    Shanghai, Shanghai 200032
    China

    Site Not Available

  • Shanghai Chest Hospital-Radiotherapy Department ( Site 0306)

    Shanghai, Shanghai 200030
    China

    Site Not Available

  • Shanghai Pulmonary Hospital-Radiotherapy department ( Site 0335)

    Shanghai, Shanghai 200433
    China

    Site Not Available

  • Shanxi Cancer Hospital-Pulmonology ( Site 0322)

    Taiyuan, Shanxi 030013
    China

    Site Not Available

  • West China Hospital of Sichuan University ( Site 0324)

    Cheng Du, Sichuan 610041
    China

    Site Not Available

  • Tianjin Cancer Hospital ( Site 0329)

    Tianjin, Tianjin 300060
    China

    Site Not Available

  • Tianjin Medical University Cancer Institute and Hospital-radiotherapy ( Site 0329)

    Tianjin, Tianjin 300060
    China

    Active - Recruiting

  • Hangzhou Cancer Hospital-Medical Oncology ( Site 0302)

    Hangzhou, Zhejiang 310002
    China

    Site Not Available

  • The Second Affiliated hospital of Zhejiang University school of medicine ( Site 0301)

    Hangzhou, Zhejiang 310009
    China

    Site Not Available

  • Zhejiang Cancer Hospital ( Site 0308)

    Hangzhou, Zhejiang 310022
    China

    Site Not Available

  • CIMCA ( Site 0501)

    San José, San Jose 10103
    Costa Rica

    Site Not Available

  • PROCLINICAL Pharma ( Site 0504)

    San José, San Jose 11303
    Costa Rica

    Site Not Available

  • Hospital Metropolitano - Sede Lindora ( Site 0503)

    Santa Ana, San Jose 10903
    Costa Rica

    Site Not Available

  • Masarykuv onkologicky ustav ( Site 3500)

    Brno, Brno-mesto 656 53
    Czechia

    Site Not Available

  • Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 3502)

    Ostrava, Moravskoslezsky Kraj 708 52
    Czechia

    Site Not Available

  • Instituto de Oncologia ( Site 3003)

    Santo Domingo, Distrito Nacional 10102
    Dominican Republic

    Site Not Available

  • Onconet ( Site 3002)

    Distrito Nacional, Santo Domingo 10148
    Dominican Republic

    Site Not Available

  • Klinikum Chemnitz-Klinik für Innere Medizin IV ( Site 0607)

    Chemnitz, Sachsen 09116
    Germany

    Site Not Available

  • LungenClinic Grosshansdorf-Onkologie ( Site 0602)

    Grosshansdorf, Schleswig-Holstein 22927
    Germany

    Site Not Available

  • Universitaetsklinikum Schleswig-Holstein Campus Kiel-Medizinische Klinik II, Hämatologie und Onkolo

    Kiel, Schleswig-Holstein 24105
    Germany

    Site Not Available

  • Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 0603

    Berlin, 13353
    Germany

    Site Not Available

  • Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 0706)

    Athens, Attiki 115 28
    Greece

    Site Not Available

  • Errikos Dunant Hospital Center-Second Department of Oncology and Clinical Trials Unit ( Site 0703)

    Athens, Attiki 115 26
    Greece

    Site Not Available

  • Metropolitan Hospital ( Site 0702)

    Athens, Attiki 185 47
    Greece

    Site Not Available

  • Sotiria Thoracic Diseases Hospital of Athens ( Site 0704)

    Athens, Attiki 11527
    Greece

    Site Not Available

  • General Oncology Hospital of Kifissia "Agioi Anargiroi"-2nd Department of Medical Oncology ( Site 07

    Nea Kifissia, Attiki 136 77
    Greece

    Site Not Available

  • University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 0700)

    Heraklion, Irakleio 715 00
    Greece

    Site Not Available

  • European Interbalkan Medical Center ( Site 0701)

    Thessaloniki, 57001
    Greece

    Site Not Available

  • Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 0802)

    Ciudad de Guatemala, 01010
    Guatemala

    Site Not Available

  • MEDI-K ( Site 0807)

    Guatemala, 01009
    Guatemala

    Site Not Available

  • MEDI-K CAYALA ( Site 0807)

    Guatemala, 01016
    Guatemala

    Active - Recruiting

  • Centro Medico Integral De Cancerología (CEMIC) ( Site 0805)

    Quetzaltenango, 09002
    Guatemala

    Site Not Available

  • Centro Regional de Sub Especialidades Médicas SA ( Site 0801)

    Quetzaltenango, 09001
    Guatemala

    Site Not Available

  • Rambam Health Care Campus-Oncology ( Site 1001)

    Haifa, 3109601
    Israel

    Site Not Available

  • Shaare Zedek Medical Center ( Site 1003)

    Jerusalem, 9103102
    Israel

    Site Not Available

  • Rabin Medical Center ( Site 1004)

    Petah Tikva, 4941492
    Israel

    Site Not Available

  • Sheba Medical Center-ONCOLOGY ( Site 1000)

    Ramat Gan, 5265601
    Israel

    Site Not Available

  • Sourasky Medical Center ( Site 1002)

    Tel Aviv, 6423906
    Israel

    Site Not Available

  • Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia medica Toraco-Polmonare ( Site 1107)

    Napoli, Campania 80131
    Italy

    Site Not Available

  • Policlinico Universitario Campus Bio-Medico-Radiation Oncology ( Site 1101)

    Roma, Lazio 00128
    Italy

    Site Not Available

  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1100)

    Milan, Lombardia 20133
    Italy

    Site Not Available

  • Ospedale San Gerardo-ASST Monza-Oncologia ( Site 1102)

    Monza, Lombardia 20900
    Italy

    Site Not Available

  • Fondazione IRCCS Policlinico San Matteo ( Site 1103)

    Pavia, Lombardia 27100
    Italy

    Site Not Available

  • Azienda Ospedaliera Spedali Civili di Brescia ( Site 1105)

    Brescia, 25123
    Italy

    Site Not Available

  • Ospedale San Raffaele ( Site 1104)

    Milano, 20132
    Italy

    Site Not Available

  • National Hospital Organization Shikoku Cancer Center ( Site 1211)

    Matsuyama, Ehime 791-0280
    Japan

    Site Not Available

  • Kurume University Hospital ( Site 1212)

    Kurume, Fukuoka 830-0011
    Japan

    Site Not Available

  • Kobe Minimally Invasive Cancer Center ( Site 1210)

    Kobe, Hyogo 650-0046
    Japan

    Site Not Available

  • Kanagawa cancer center ( Site 1204)

    Yokohama, Kanagawa 241-8515
    Japan

    Site Not Available

  • Miyagi Cancer Center ( Site 1200)

    Natori, Miyagi 981-1293
    Japan

    Site Not Available

  • Sendai Kousei Hospital ( Site 1213)

    Sendai, Miyagi 981-0914
    Japan

    Site Not Available

  • Niigata Cancer Center Hospital ( Site 1205)

    Niigata-shi, Niigata 951-8566
    Japan

    Site Not Available

  • Kansai Medical University Hospital ( Site 1207)

    Hirakata, Osaka 573-1191
    Japan

    Site Not Available

  • Osaka Medical and Pharmaceutical University Hospital ( Site 1208)

    Takatsuki, Osaka 569-8686
    Japan

    Site Not Available

  • Saitama Prefectural Cancer Center ( Site 1201)

    Ina-machi, Saitama 362-0806
    Japan

    Site Not Available

  • Japanese Foundation for Cancer Research ( Site 1202)

    Koto, Tokyo 135-8550
    Japan

    Site Not Available

  • Showa University Hospital ( Site 1203)

    Shinagawa, Tokyo 142-8666
    Japan

    Site Not Available

  • Osaka International Cancer Institute ( Site 1209)

    Osaka, 541-8567
    Japan

    Site Not Available

  • Chungbuk National University Hospital-Internal medicine ( Site 2400)

    Cheongju-si, Chungbuk 28644
    Korea, Republic of

    Site Not Available

  • Ajou University Hospital-Hematology-Oncology ( Site 2402)

    Suwon-si, Kyonggi-do 16499
    Korea, Republic of

    Site Not Available

  • The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 2401)

    Suwon-si, Kyonggi-do 16247
    Korea, Republic of

    Site Not Available

  • Severance Hospital, Yonsei University Health System-Lung Cancer Center ( Site 2403)

    Seoul, 03722
    Korea, Republic of

    Site Not Available

  • University Malaya Medical Centre-Clinical Oncology ( Site 1402)

    Lembah Pantai, Kuala Lumpur 59100
    Malaysia

    Site Not Available

  • Hospital Pulau Pinang ( Site 1400)

    George Town, Pulau Pinang 10450
    Malaysia

    Site Not Available

  • Hospital Kuala Lumpur-Radiotherapy and Oncology ( Site 1401)

    Kuala Lumpur, 50586
    Malaysia

    Site Not Available

  • Arké SMO S.A. de C.V. ( Site 1504)

    Mexico, Distrito Federal 06700
    Mexico

    Site Not Available

  • Actualidad Basada en la Investigación del Cáncer-Lung Cancer ( Site 1505)

    Guadalajara, Jalisco 44680
    Mexico

    Site Not Available

  • Centro Oncologico de Chihuahua-Unidad de Investigacion Clinica ( Site 1507)

    Chihuahua, 31217
    Mexico

    Site Not Available

  • Centro de Investigacion Clinica de Oaxaca ( Site 1501)

    Oaxaca, 68020
    Mexico

    Site Not Available

  • THE MEDICAL CITY-Cancer Research Center ( Site 3200)

    Pasig, National Capital Region 1605
    Philippines

    Site Not Available

  • Veterans Memorial Medical Center-Section of Oncology ( Site 3201)

    Quezon City, National Capital Region 1100
    Philippines

    Site Not Available

  • Champalimaud Foundation ( Site 2003)

    Lisbon, Lisboa 1400-038
    Portugal

    Site Not Available

  • Hospital CUF Descobertas ( Site 2006)

    Lisbon, Lisboa 1998-018
    Portugal

    Site Not Available

  • Centro Hospitalar do Porto - Hospital de Santo António ( Site 2004)

    Porto, 4099-001
    Portugal

    Active - Recruiting

  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2001)

    Porto, 4200-072
    Portugal

    Site Not Available

  • Unidade Local de Saude de Santo António - Hospital Santo António ( Site 2004)

    Porto, 4099-001
    Portugal

    Site Not Available

  • Centrul Medical Medicover Victoria ( Site 2106)

    Bucharest, Bucuresti 010626
    Romania

    Site Not Available

  • Amethyst Radiotherapy Center ( Site 2102)

    Florești, Cluj 407280
    Romania

    Site Not Available

  • Centrul de Oncologie "Sfântul Nectarie" ( Site 2100)

    Craiova, Dolj 200542
    Romania

    Site Not Available

  • Radiology Therapeutic Center ( Site 2108)

    Otopeni, Ilfov 075100
    Romania

    Site Not Available

  • Cabinet Medical Oncomed ( Site 2101)

    Timisoara, Timis 300239
    Romania

    Site Not Available

  • Cabinet Medical Oncomed ( Site 2101)

    Timișoara, Timis 300239
    Romania

    Site Not Available

  • Centrul Medical Neolife- Baneasa ( Site 2110)

    Bucuresti, 077190
    Romania

    Site Not Available

  • CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 2304)

    Port Elizabeth, Eastern Cape 6055
    South Africa

    Site Not Available

  • Wilgers Oncology Centre ( Site 2301)

    Pretoria, Gauteng 0040
    South Africa

    Site Not Available

  • The Oncology Centre ( Site 2300)

    Durban, Kwazulu-Natal 4091
    South Africa

    Site Not Available

  • Abraham Oncology ( Site 2303)

    Richards Bay, Kwazulu-Natal 3900
    South Africa

    Site Not Available

  • Cape Town Oncology Trials ( Site 2306)

    Cape Town, Western Cape 7570
    South Africa

    Site Not Available

  • HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Sit

    Barcelona, Cataluna 08036
    Spain

    Site Not Available

  • Hospital Universitari Vall d'Hebron ( Site 2501)

    Barcelona, Cataluna 08035
    Spain

    Site Not Available

  • CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 2502)

    Santiago de Compostela, La Coruna 15706
    Spain

    Site Not Available

  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2504)

    Pozuelo de Alarcon, Madrid, Comunidad De 28223
    Spain

    Site Not Available

  • Medipol Mega Universite Hastanesi-oncology ( Site 2611)

    Stanbul, Istanbul 34214
    Turkey

    Site Not Available

  • Ege University Medicine of Faculty-Chest Diseases Department ( Site 2603)

    Bornova, Izmir 35100
    Turkey

    Site Not Available

  • I.E.U. Medical Point Hastanesi-Oncology ( Site 2612)

    Izmir, Karsiyaka, Izmir 009035575
    Turkey

    Site Not Available

  • Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 2607)

    Adana, 01250
    Turkey

    Site Not Available

  • Ankara City Hospital-Medical Oncology ( Site 2601)

    Ankara, 06800
    Turkey

    Site Not Available

  • Ankara Gülhane Eitim ve Aratrma Hastanesi-Oncology ( Site 2602)

    Ankara, 06010
    Turkey

    Site Not Available

  • Hacettepe Universitesi-oncology hospital ( Site 2605)

    Ankara, 06230
    Turkey

    Site Not Available

  • Memorial Ankara Hastanesi-Medical Oncology ( Site 2609)

    Ankara, 06520
    Turkey

    Site Not Available

  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2610)

    Istanbul, 34722
    Turkey

    Site Not Available

  • I.E.U. Medical Point Hastanesi-Oncology ( Site 2612)

    Izmir, 35575
    Turkey

    Site Not Available

  • Limited Liability Company Ukrainian Center of Tomotherapy-Department of Chemotherapy ( Site 2905)

    Kropyvnytskyi, Kirovohradska Oblast 25011
    Ukraine

    Site Not Available

  • Municipal non-profit enterprise "Lviv Territorial Medical Union "Multidisciplinary Clinical Hospital

    Lviv, Lvivska Oblast 79000
    Ukraine

    Site Not Available

  • Rivne Regional Clinical Hospital ( Site 2919)

    Rivne, Rivnenska Oblast 33007
    Ukraine

    Site Not Available

  • Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council"

    Vinnytsia, Vinnytska Oblast 21029
    Ukraine

    Site Not Available

  • Volyn Regional clinical hospital. Regional Medical Oncology Centre. Oncology chemotherapy department

    Lutsk, Volynska Oblast 43018
    Ukraine

    Site Not Available

  • Universal Clinic Oberig-Oncology Center ( Site 2916)

    Kyiv, 03057
    Ukraine

    Site Not Available

  • VA Long Beach Healthcare System ( Site 2831)

    Long Beach, California 90822
    United States

    Site Not Available

  • VA West Los Angeles Medical Center ( Site 2808)

    Los Angeles, California 90073
    United States

    Site Not Available

  • Millennium Oncology Research Clinic ( Site 2801)

    Hollywood, Florida 33024
    United States

    Site Not Available

  • Mid Florida Hematology and Oncology Center ( Site 2800)

    Orange City, Florida 32763
    United States

    Site Not Available

  • Moffitt Cancer Center ( Site 2818)

    Tampa, Florida 33612
    United States

    Site Not Available

  • University of Chicago Medical Center ( Site 2828)

    Chicago, Illinois 60637
    United States

    Site Not Available

  • Franciscan St. Francis Health ( Site 2812)

    Indianapolis, Indiana 46237
    United States

    Site Not Available

  • MFSMC-HJWCI ( Site 2804)

    Baltimore, Maryland 21237
    United States

    Site Not Available

  • Boston Medical Center ( Site 2829)

    Boston, Massachusetts 02118
    United States

    Site Not Available

  • University of Massachusetts Chan Medical School ( Site 2815)

    Worcester, Massachusetts 01655
    United States

    Site Not Available

  • University of Missouri Hospital ( Site 2839)

    Columbia, Missouri 65212
    United States

    Site Not Available

  • Cox Medical Center North-Cox Medical Center/Hulston Cancer Center/ Radiation Oncology ( Site 2837)

    Springfield, Missouri 65807
    United States

    Site Not Available

  • Rutgers Cancer Institute of New Jersey ( Site 2805)

    New Brunswick, New Jersey 08903
    United States

    Site Not Available

  • Icahn School of Medicine at Mount Sinai ( Site 2821)

    New York, New York 10029
    United States

    Site Not Available

  • White Plains Hospital ( Site 2835)

    White Plains, New York 10601
    United States

    Site Not Available

  • Kaiser Permanente Northwest-Central Interstate--Oncology ( Site 2816)

    Portland, Oregon 97227
    United States

    Site Not Available

  • Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 2827)

    Lancaster, Pennsylvania 17601
    United States

    Site Not Available

  • Thomas Jefferson University - Clinical Research Institute ( Site 2813)

    Philadelphia, Pennsylvania 19107
    United States

    Site Not Available

  • Millennium Research & Clinical Development ( Site 2811)

    Houston, Texas 77090
    United States

    Site Not Available

  • Central Texas Veterans health care-Oncology & Hematology ( Site 2819)

    Temple, Texas 76504
    United States

    Site Not Available

  • MultiCare Health System ( Site 2817)

    Tacoma, Washington 98405
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.